BEATS = 100
CYCLELENGTH=  1000
CELLTYPES= ENDO
IGNORE_STEADYSTATE ENDO
STEADY_STATE_VARIABLE VOLTAGE
MYOCYTE= MODIFIED $ MODIFIED or NORMAL + MALE OR FEMALE (AT 600bcl) or NORMAL PIG $ FDA model optimization
$------------------------
CONDUCTANCES  
INAME= Default OHARA

$---1 conductance ito channel (GIto) ****
1.0 1.0 1.0

$---2 conductance slow potassium channel (GKs) 
1.0 1.0 1.0

$---3 conductance potassium channel (GK1) ****
1.0 1.0 1.0

$---4 conductance rapid potassium channel (GKr) 
1.0 1.0 1.0

$---5 conductance sodium channel (GNa) 
1.0 1.0 1.0

$---6 conductance late sodium channel (GNaL)  **** 
1.0 1.0 1.0

$---7 conductance sodium calcium exchanger (GNaCa) **** 
1.0 1.0 1.0

$---8 background potassium background current conductance (gKb) 
1.0 1.0 1.0

$---9 L-type calcium current permeability (pCa equiv to gCaL)  
1.0 1.0 1.0

$---10 sodium potassium pump current permeability (pNaK) **** 
1.0 1.0 1.0

$---11 Calmodulin **** (camka)
1.0 1.0 1.0

$---12 Serca Pump (Jup) *** 
1.0 1.0 1.0

$---13 Na0 Ca0 K0 concentrations percentage of change of concentration  Na0=140, Ca0=1.8, K0=5.4
1.0 1.0 1.0  

$---14 IKatp for ischemia
0.0 0.0 0.0 

$---15 Jleak  **** 
1.0 1.0 1.0

$---16 JrelNP aproximate Ca sensitivity  
1.0 1.0 1.0

$---17 Inal TauHL  **** 
1.0 1.0 1.0
 
END_CONDUCTANCES
$------------------------
